DLA Piper advised Predictive Oncology in US$343.5 million digital asset treasury launch

DLA Piper advised Predictive Oncology Inc. (“Predictive Oncology”) in connection with US$343.5 million of private placements of common stock and pre-funded warrants to support its adoption of a digital asset treasury strategy.

Predictive Oncology’s principal holding will be ATH, the native utility token of the Aethir ecosystem. Aethir is a leading AI decentralized physical infrastructure network that provides graphics processing units for applications including AI computation, gaming, and cloud workloads.

The DLA Piper team was led by Partner Raymond Miller, Senior Attorney David Smith and Associate Dylan Caplan (all Philadelphia), and Partners Josh Kaufman (New York/ Miami) and Era Anagnosti (Washington DC/Palo Alto). The team also included Associates Alex Carlson, Kenneth Rowles (both Los Angeles), and Michael Kumar (New York).

DLA Piper enables issuers and underwriters to execute complex securities transactions throughout the world. We offer tactical approaches to financings across equity and debt capital markets, alternative public offerings (de-SPACs, reverse mergers, and direct listings), and other transformative corporate transactions. Attorneys in our corporate governance practice act as outside corporate and securities counsel to a wide range of reporting companies by guiding clients through securities offerings and nuanced disclosure, governance, and compliance matters under SEC, Nasdaq, and NYSE rules and regulations. Boards of directors turn to us to navigate complex transactions, special investigations, and challenging risk oversight matters.